This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AMN Healthcare (AMN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare (AMN) issues upbeat revenue guidance for the third quarter of 2019.
AMN Healthcare Services (AMN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 10.00% and 1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
AMN or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
Earnings Preview: AMN Healthcare Services (AMN) Q2 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Near-Term Outlook for Medical Services Industry Looks Bright
by Urmimala Biswas
The third-party medical services industry is expanding rapidly.
AMN or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
HealthEquity (HQY) in Focus: Stock Moves 6.7% Higher
by Zacks Equity Research
HealthEquity (HQY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Zacks.com featured highlights include: AMN, Kemper, United Airlines and UniFirst
by Zacks Equity Research
Zacks.com featured highlights include: AMN, Kemper, United Airlines and UniFirst
Why AMN Healthcare (AMN) Could Beat Earnings Estimates Again
by Zacks Equity Research
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Stocks With Relative Price Strength to Enhance Your Gains
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
AMN vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
All You Need to Know About AMN Healthcare (AMN) Rating Upgrade to Strong Buy
by Zacks Equity Research
AMN Healthcare (AMN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for July 3rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
AMN Healthcare (AMN) Closes Advanced Medical Acquisition
by Zacks Equity Research
AMN Healthcare (AMN) completes Advanced Medical buyout that will help the former to boost offerings in some of the fastest growing and very important care settings.
Why Is AMN Healthcare (AMN) Down 4.6% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AMN Healthcare (AMN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Higher revenues and expansion in gross margin find reflection in AMN Healthcare's (AMN) Q1 results. However, weak performance at Nurse and Allied and Locum Tenens segments remain woes.
AMN Healthcare Services (AMN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 8.70% and 1.45%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN Healthcare Down on Soft Locum Tenens Business, Dull View
by Zacks Equity Research
Dependence on third parties is detrimental for AMN Healthcare (AMN).
AMN Healthcare (AMN) Q4 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) Q4 results get a boost from Nurse and Allied Solutions and Other Workforce Solutions segments.
New Strong Sell Stocks for March 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
AMN Healthcare Services (AMN) Q4 Earnings Top Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 1.25% and -1.97%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
AMN Healthcare Services (AMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Teladoc in 2019, After a Strong 2018?
by Zacks Equity Research
Teladoc (TDOC) should continue to gain from increasing demand for its services and global expansion.
Cigna Poised for Growth in 2019 on Express Scripts Buyout
by Zacks Equity Research
The purchase of Express Scripts by Cigna (CI) has diversified its business, which should fuel long-term growth.